title: Th-17 and the lack of efficacy of ustekinumab in pemphigus vulgaris.
abstract: Systemic corticosteroids represent an effective treatment for pemphigus vulgaris (PV). However, this treatment is related to many adverse side effects. Herein, we report a case of PV treated with ustekinumab.
authors.affiliation: Servicio de Dermatología, Hospital General de México.
authors.forename: Andrés
authors.initials: A
authors.lastname: Tirado-Sánchez
authors.forename: Rosa María
authors.initials: RM
authors.lastname: Ponce-Olivera
authors.forename: Denisse
authors.initials: D
authors.lastname: Vazquez-González
authors.forename: Alexandro
authors.initials: A
authors.lastname: Bonifaz
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D016207:Cytokines / Q000097:blood; D051184:Desmoglein 3 / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008297:Male; D010392:Pemphigus / Q000188:drug therapy*; D058504:Th17 Cells / Q000276:immunology*; D000069549:Ustekinumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D016207:Cytokines; D051184:Desmoglein 3; D000069549:Ustekinumab